JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 43(2009) N 2 p. 348-352;
E.V. Spitsina1, G.N. Svetlova2, D.A. Chudakova1, A.G. Nikitin1, T.L. Kurayeva2, I.A. Strokov3, V.V. Nosikov1

Association of the POLG1T(-365)C, ANT1 G(-25)A, and PEO1 G(-605)T polymorphisms with diabetic polyneuropathy in patients with Type 1 diabetes mellitus

1State Research Center GosNIIgenetika, Moscow, 117545, Russia
2Endocrinology Research Center, Moscow, 117036, Russia
3Sechenov Moscow Medical Academy, Moscow, 119992, Russia
Received - 2008-08-06; Accepted - 2008-11-24

This study is dedicated to a search for the association of the polymorphic markers T (-365)C of the POLG1 gene G(-25)A of the ANT1 gene and G(-605)T of the PEO1 gene with diabetic polyneuropathy (DPN) in Type 1 diabetes mellitus (DM1) patients. All patients were ethnic Russian Moscow residents, with DM1 records of no more than 5 years and DPN or DM1 records of more than 10 years but without DPN. We found that the polymorphic marker T(-365)C of POLG1 was associated with DPN in Russian patients with DM1. The carriers of the C allele and the CC genotype had a higher risk of DPN development (OR = 1.62; CI = 1.11-2.38; and OR = 1.76; CI = 0.99-3.13; respectively). In contrast, the T allele carrier status and the TT genotype were associated with a lower DPN risk (OR = 0.62, CI = 0.42-0.90; and OR = 0.61; CI = 0.35-1.07; respectively). We found no association of the polymorphic markers G(-25)A of ANT1 or G(-605)T of PEO1 with DPN in Russian DM1 patients living in Moscow.

diabetic polyneuropathy, POLG1, ANT1, PEO1, association, polymorphic markers



JMB-FOOTER RAS-JOURNALS